NCT02982798

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Jeil Pharmaceutical Co., Ltd. · Industry
• Sex: Male
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A randomized, open-label, single dose, crossover study to compare the pharmacokinetic characteristics of the co-administration of metformin SR and rosuvastatin and JLP-1310 in healthy male volunteers

Detailed description

A randomized, open-label, single dose, crossover clinical trial

Conditions

• Diabetes
• Hyperlipidemia

Interventions

Type	Name	Description
DRUG	Metformin + Rosuvastatin	administration of Metformin + Rosuvastatin
DRUG	JLP-1310	administration of JLP-1310

Timeline

• Start date: 2017-07-06
• Primary completion: 2017-08-30
• Completion: 2018-01-31
• First posted: 2016-12-05
• Last updated: 2018-03-29

Locations

1 site across 1 country: South Korea